- Headquarters
- Princeton, United States · North America
- Value chain
- Medicines & vaccines(Products)
- What that means
- Develops and sells therapeutics under its own name: drugs, biologics, vaccines, cell and gene therapies and radiopharmaceuticals.
- Founded
- 1887
- Staff
- 34,100 (2024)
- Ownership
- Listed
- Listing
- NYSE:BMY on Google Finance
- Website
- bms.com
- Relevance
- Moderate at its strongest, in Nuclear Medicine & Radioisotope Technologies
In 1 capability
Each capability the company is listed in, most relevant first: how experts in the field see its global relevance there, why it is listed and the source.
Biotechnology & Health Technologies · Design · listed #22 of 50
Acquired RayzeBio in 2024 for its actinium-225 radiopharmaceutical pipeline (RYZ101) and Ac-225 manufacturing capacity in Indiana.
Relevance: Significant actinium-225 radiopharmaceutical pipeline